Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C15H10Cl2N2O |
| Molecular Weight | 305.159 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
ClC1=CC=C2NC(=O)CN=C(C3=CC=CC=C3Cl)C2=C1
InChI
InChIKey=CHIFCDOIPRCHCF-UHFFFAOYSA-N
InChI=1S/C15H10Cl2N2O/c16-9-5-6-13-11(7-9)15(18-8-14(20)19-13)10-3-1-2-4-12(10)17/h1-7H,8H2,(H,19,20)
Delorazepam is a benzodiazepine with anxiolytic effects. It is a metabolite of the designer drug diclazepam that can be detected in either the serum or urine. Delorazepam can also be produced by enzymatic treatment of lorazepam with β-glucuronidase. It is indicated for the treatment of anxiety, tension and other somatic or psychiatric manifestations associated with anxiety syndrome, insomnia. The side effects and precautions for use of delorazepam are the same as for all benzodiazepines, in particular as regards the development of dependence (mental and physical) and tolerance. Prolonged use may lead to difficulties remembering recent names and events (anterograde amnesia). It has been approved for marketing in Italy.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Quantification of chlordesmethyldiazepam by liquid chromatography-tandem mass spectrometry: application to a cloxazolam bioequivalence study. | 2009-12 |
|
| Treatment with aripiprazole and topiramate in an obese subject with borderline personality disorder, obsessive-compulsive symptoms and bulimia nervosa: a case report. | 2009-07-23 |
|
| GABA(A) receptors in normal development and seizures: friends or foes? | 2008-03 |
|
| An observational study in psychiatric acute patients admitted to General Hospital Psychiatric Wards in Italy. | 2007-01-27 |
|
| SPME-LC with UV detection to study delorazepam-serum albumin interactions. | 2002-07-31 |
|
| Determination of delorazepam in urine by solid-phase microextraction coupled to high performance liquid chromatography. | 2002-06-01 |
|
| Psychotic affective disorder after nicotine withdrawal. | 1994-03 |
|
| Participation of GABAergic mechanisms in the hypotensive and bradycardic effects of clonidine: experimental study in conscious normotensive and hypertensive rats. | 1987-10 |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
DEA NO. |
2754
Created by
admin on Mon Mar 31 18:00:17 GMT 2025 , Edited by admin on Mon Mar 31 18:00:17 GMT 2025
|
||
|
NCI_THESAURUS |
C1012
Created by
admin on Mon Mar 31 18:00:17 GMT 2025 , Edited by admin on Mon Mar 31 18:00:17 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C98132
Created by
admin on Mon Mar 31 18:00:17 GMT 2025 , Edited by admin on Mon Mar 31 18:00:17 GMT 2025
|
PRIMARY | |||
|
DELORAZEPAM
Created by
admin on Mon Mar 31 18:00:17 GMT 2025 , Edited by admin on Mon Mar 31 18:00:17 GMT 2025
|
PRIMARY | |||
|
111762
Created by
admin on Mon Mar 31 18:00:17 GMT 2025 , Edited by admin on Mon Mar 31 18:00:17 GMT 2025
|
PRIMARY | |||
|
SUB06957MIG
Created by
admin on Mon Mar 31 18:00:17 GMT 2025 , Edited by admin on Mon Mar 31 18:00:17 GMT 2025
|
PRIMARY | |||
|
100000090622
Created by
admin on Mon Mar 31 18:00:17 GMT 2025 , Edited by admin on Mon Mar 31 18:00:17 GMT 2025
|
PRIMARY | |||
|
220-771-9
Created by
admin on Mon Mar 31 18:00:17 GMT 2025 , Edited by admin on Mon Mar 31 18:00:17 GMT 2025
|
PRIMARY | |||
|
169895
Created by
admin on Mon Mar 31 18:00:17 GMT 2025 , Edited by admin on Mon Mar 31 18:00:17 GMT 2025
|
PRIMARY | |||
|
2894-67-9
Created by
admin on Mon Mar 31 18:00:17 GMT 2025 , Edited by admin on Mon Mar 31 18:00:17 GMT 2025
|
PRIMARY | |||
|
O91W32476G
Created by
admin on Mon Mar 31 18:00:17 GMT 2025 , Edited by admin on Mon Mar 31 18:00:17 GMT 2025
|
PRIMARY | |||
|
DB01511
Created by
admin on Mon Mar 31 18:00:17 GMT 2025 , Edited by admin on Mon Mar 31 18:00:17 GMT 2025
|
PRIMARY | |||
|
CHEMBL268254
Created by
admin on Mon Mar 31 18:00:17 GMT 2025 , Edited by admin on Mon Mar 31 18:00:17 GMT 2025
|
PRIMARY | |||
|
C013434
Created by
admin on Mon Mar 31 18:00:17 GMT 2025 , Edited by admin on Mon Mar 31 18:00:17 GMT 2025
|
PRIMARY | |||
|
DTXSID70183137
Created by
admin on Mon Mar 31 18:00:17 GMT 2025 , Edited by admin on Mon Mar 31 18:00:17 GMT 2025
|
PRIMARY | |||
|
4510
Created by
admin on Mon Mar 31 18:00:17 GMT 2025 , Edited by admin on Mon Mar 31 18:00:17 GMT 2025
|
PRIMARY | |||
|
17925
Created by
admin on Mon Mar 31 18:00:17 GMT 2025 , Edited by admin on Mon Mar 31 18:00:17 GMT 2025
|
PRIMARY | |||
|
800
Created by
admin on Mon Mar 31 18:00:17 GMT 2025 , Edited by admin on Mon Mar 31 18:00:17 GMT 2025
|
PRIMARY |
ACTIVE MOIETY